IDT

IDT AUST FPO [IDT]
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Healthcare · ASX Small Cap
$0.0320 -3.0%

Updated 14 Jul 2026 · Signals refresh every scan

Get alerts when IDT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track IDT — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.7x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (4% of range)
  • Micro-cap ($5-20M) - high risk
  • CANSLIM I: Institutional ownership (18%)
  • Sentiment is mixed — no strong consensus either way
  • Altman Z-Score distress zone (1.69 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.033)
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Revenue declining (-7%)
  • Deeply negative margins (-32%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 46% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.43%/day)
Ask Scout AI about IDT
"What's driving IDT today?" "How does IDT compare to peers?" "Key risks for IDT?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification of cessation of securities - IDT

Recent ASX Announcements

2026-06-12 Notification of cessation of securities - IDT

Key Metrics

$14.1M
Market Cap
330K
Avg Volume
0.8x
Vol Ratio
$0.03 — $0.11
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-26.1%
ROE
-32.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 72%
LLeader vs LaggardlaggardRS: -12
IInstitutional SponsorshippassInst: 18%
MMarket DirectionneutralNeutral

Sector: Healthcare

109 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
ECS -20.0%MEM -12.5%NTI +12.5%VBS +11.4%BDX +11.0%
Compare:IDT vs ECSIDT vs MEMIDT vs NTI
Scout Pro — Deeper Analysis for IDT
Try Pro free for 30 days
Share this analysis

Track IDT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required